Tuberculosis innovations mean little if they cannot save lives

Madhukar Pai, Jennifer Furin

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

The past decade has seen the emergence of new diagnostics and drugs for tuberculosis, a disease that kills over 1.8 million people each year. However, these new tools are yet to reach scale, and access remains a major challenge for patients in low and middle income countries. Urgent action is needed if we are committed to ending the TB epidemic. This means raising the level of ambition, embracing innovation, increasing financial investments, addressing implementation gaps, and ensuring that new technologies reach those who need them to survive. Otherwise, the promise of innovative technologies will never be realized.

Original languageEnglish
Article numbere25956
JournaleLife
Volume6
DOIs
Publication statusPublished - 02-05-2017

Fingerprint

Tuberculosis
Innovation
Technology
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Neuroscience(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)

Cite this

@article{96fc30c4e50c446aa4bf30c8624b8c0c,
title = "Tuberculosis innovations mean little if they cannot save lives",
abstract = "The past decade has seen the emergence of new diagnostics and drugs for tuberculosis, a disease that kills over 1.8 million people each year. However, these new tools are yet to reach scale, and access remains a major challenge for patients in low and middle income countries. Urgent action is needed if we are committed to ending the TB epidemic. This means raising the level of ambition, embracing innovation, increasing financial investments, addressing implementation gaps, and ensuring that new technologies reach those who need them to survive. Otherwise, the promise of innovative technologies will never be realized.",
author = "Madhukar Pai and Jennifer Furin",
year = "2017",
month = "5",
day = "2",
doi = "10.7554/eLife.25956.001",
language = "English",
volume = "6",
journal = "eLife",
issn = "2050-084X",
publisher = "eLife Sciences Publications",

}

Tuberculosis innovations mean little if they cannot save lives. / Pai, Madhukar; Furin, Jennifer.

In: eLife, Vol. 6, e25956, 02.05.2017.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Tuberculosis innovations mean little if they cannot save lives

AU - Pai, Madhukar

AU - Furin, Jennifer

PY - 2017/5/2

Y1 - 2017/5/2

N2 - The past decade has seen the emergence of new diagnostics and drugs for tuberculosis, a disease that kills over 1.8 million people each year. However, these new tools are yet to reach scale, and access remains a major challenge for patients in low and middle income countries. Urgent action is needed if we are committed to ending the TB epidemic. This means raising the level of ambition, embracing innovation, increasing financial investments, addressing implementation gaps, and ensuring that new technologies reach those who need them to survive. Otherwise, the promise of innovative technologies will never be realized.

AB - The past decade has seen the emergence of new diagnostics and drugs for tuberculosis, a disease that kills over 1.8 million people each year. However, these new tools are yet to reach scale, and access remains a major challenge for patients in low and middle income countries. Urgent action is needed if we are committed to ending the TB epidemic. This means raising the level of ambition, embracing innovation, increasing financial investments, addressing implementation gaps, and ensuring that new technologies reach those who need them to survive. Otherwise, the promise of innovative technologies will never be realized.

UR - http://www.scopus.com/inward/record.url?scp=85018902264&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018902264&partnerID=8YFLogxK

U2 - 10.7554/eLife.25956.001

DO - 10.7554/eLife.25956.001

M3 - Article

AN - SCOPUS:85018902264

VL - 6

JO - eLife

JF - eLife

SN - 2050-084X

M1 - e25956

ER -